Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

222 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evolution of monoclonal gammopathy of undetermined significance in patients treated with JAK inhibitors for rheumatic diseases: data from the MAJIK-SFR registry.
Faganello D, Bertrand A, Meunier P, Avouac J, Toussirot E, Coury F, Seror R, Le Mélédo G, Germain V, Dellal A, Shima D, Hulin C, Prati C, Schaeverbeke T, Richez C, Truchetet ME, Kostine M. Faganello D, et al. Among authors: richez c. Rheumatology (Oxford). 2024 Mar 1;63(3):787-790. doi: 10.1093/rheumatology/kead187. Rheumatology (Oxford). 2024. PMID: 37540112
COVID-19 presentation and outcomes in patients with inflammatory rheumatic and musculoskeletal diseases receiving IL6-receptor antagonists prior to SARS-CoV-2 infection.
Comarmond C, Drumez E, Labreuche J, Hachulla E, Thomas T, Flipo RM, Seror R, Avouac J, Balandraud N, Desbarbieux R, Felten R, Gilson M, Guyot MH, Hittinger-Roux A, Pham T, Renard M, Roux N, Sobanski V, Tournadre A, Richez C, Cacoub P; FAI2 R/SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors. Comarmond C, et al. Among authors: richez c. J Transl Autoimmun. 2023 Jan 14;6:100190. doi: 10.1016/j.jtauto.2023.100190. eCollection 2023. J Transl Autoimmun. 2023. PMID: 36684808 Free PMC article.
CovAID: Identification of factors associated with severe COVID-19 in patients with inflammatory rheumatism or autoimmune diseases.
Chevalier K, Genin M, Jean TP, Avouac J, Flipo RM, Georgin-Lavialle S, El Mahou S, Pertuiset E, Pham T, Servettaz A, Marotte H, Domont F, Chazerain P, Devaux M, Mekinian A, Sellam J, Fautrel B, Rouzaud D, Ebstein E, Costedoat-Chalumeau N, Richez C, Hachulla E, Mariette X, Seror R. Chevalier K, et al. Among authors: richez c. Front Med (Lausanne). 2023 Mar 22;10:1152587. doi: 10.3389/fmed.2023.1152587. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37035330 Free PMC article.
Comparing COVID-19 disease severity in patients with rheumatic and inflammatory diseases between the first and the subsequent waves.
Drumez E, Richez C, Bebear L, Herasse M, Flipo RM, Marotte H, Georgin-Lavialle S, Seror R, Pertuiset E, Avouac J, Chazerain P, Roux N, Pham T, Dernis E, Uzunhan Y, Servettaz A, El Mahou S, Cacoub P, Hamidou M, Fautrel B, Thomas T, Hachulla E; Consortium; contributors. Drumez E, et al. Among authors: richez c. Joint Bone Spine. 2023 Sep;90(5):105605. doi: 10.1016/j.jbspin.2023.105605. Epub 2023 Jul 1. Joint Bone Spine. 2023. PMID: 37399939 No abstract available.
Factors associated with COVID-19 severity in patients with spondyloarthritis: Results of the French RMD COVID-19 cohort.
Perrot L, Boyer L, Flipo RM, Marotte H, Pertuiset E, Miceli C, Thomas T, Seror R, Chazerain P, Roux N, Richez C, Pham T; FAI2R/SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium. Perrot L, et al. Among authors: richez c. Joint Bone Spine. 2023 Dec;90(6):105608. doi: 10.1016/j.jbspin.2023.105608. Epub 2023 Jul 5. Joint Bone Spine. 2023. PMID: 37414137
Towards the Lowest Efficacious Dose: Results From a Multicenter Noninferiority Randomized Open-Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in Remission.
Kedra J, Dieudé P, Giboin C, Marotte H, Salliot C, Schaeverbeke T, Perdriger A, Soubrier M, Morel J, Constantin A, Dernis E, Royant V, Salmon JH, Pham T, Gottenberg JE, Pertuiset E, Dougados M, Devauchelle-Pensec V, Gaudin P, Cormier G, Goupille P, Mariette X, Berenbaum F, Alcaix D, Rouidi SA, Berthelot JM, Monnier A, Piroth C, Lioté F, Goëb V, Gaujoux-Viala C, Chary-Valckenaere I, Hajage D, Tubach F, Fautrel B; CRI‐IMIDIATE clinical research network. Kedra J, et al. Arthritis Rheumatol. 2024 Apr;76(4):541-552. doi: 10.1002/art.42752. Epub 2024 Jan 25. Arthritis Rheumatol. 2024. PMID: 37942714 Clinical Trial.
Immune checkpoint inhibitor rechallenge in patients who previously experienced immune-related inflammatory arthritis: a multicentre observational study.
Ladouceur A, Barnetche T, Mouterde G, Tison A, Bitoun S, Prey S, Dutriaux C, Gerard E, Pham-Ledard A, Beylot-Barry M, Zysman M, Veillon R, Domblides C, Daste A, Gross-Goupil M, Sionneau B, Lefort F, Larroquette M, Richez C, Truchetet ME, Schaeverbeke T, Kostine M. Ladouceur A, et al. Among authors: richez c. RMD Open. 2023 Nov 29;9(4):e003795. doi: 10.1136/rmdopen-2023-003795. RMD Open. 2023. PMID: 38030233 Free PMC article.
Diagnosis and treatment of Tropheryma whipplei infection in patients with inflammatory rheumatic disease: Data from the French Tw-IRD registry.
Caillet Portillo D, Puéchal X, Masson M, Kostine M, Michaut A, Ramon A, Wendling D, Costedoat-Chalumeau N, Richette P, Marotte H, Vix-Portet J, Dubost JJ, Ottaviani S, Mouterde G, Grasland A, Frazier A, Germain V, Coury F, Tournadre A, Soubrier M, Cavalie L, Brevet P, Zabraniecki L, Jamard B, Couture G, Arnaud L, Richez C, Degboé Y, Ruyssen-Witrand A, Constantin A. Caillet Portillo D, et al. Among authors: richez c. J Infect. 2024 Feb;88(2):132-138. doi: 10.1016/j.jinf.2023.12.010. Epub 2023 Dec 22. J Infect. 2024. PMID: 38141787 Free article.
222 results